Prokidney (PROK) Interest Coverage Ratio Growth (3y) (2024 - 2026)
Powered by 
Analysis
Prokidney (PROK) Interest Coverage Ratio Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -32.02% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 27.44% |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 27.02% |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 27.40% |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | -69.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.38% |
| Mar 31, 2026 | 39.65% |
| Dec 31, 2025 | -44.24% |
| Sep 30, 2025 | -150.45% |
| Jun 30, 2025 | -587.90% |
| Sep 30, 2024 | -12.76% |